Global Anti Obesity Drugs Sales Market Report 2016

November 2016 | 118 pages | ID: G22923EDD7FEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti Obesity Drugs

Revenue, means the sales value of Anti Obesity Drugs

This report studies sales (consumption) of Anti Obesity Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Pfizer
• Merck
• Roche
• GlaxoSmithKline
• AstraZeneca
• Boehringer Ingelheim
• Novo Nordisk
• Eisai
• Norgine
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Vivus
• Alizyme
• Rhythm Pharmaceuticals
• Shionogi
• Zafgan

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Anti Obesity Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Anti Obesity Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Anti Obesity Drugs Sales Market Report 2016

1 ANTI OBESITY DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti Obesity Drugs
1.2 Classification of Anti Obesity Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Anti Obesity Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Anti Obesity Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Anti Obesity Drugs (2011-2021)
  1.5.1 Global Anti Obesity Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTI OBESITY DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Anti Obesity Drugs Market Competition by Manufacturers
  2.1.1 Global Anti Obesity Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Anti Obesity Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Anti Obesity Drugs (Volume and Value) by Type
  2.2.1 Global Anti Obesity Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Anti Obesity Drugs (Volume and Value) by Regions
  2.3.1 Global Anti Obesity Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Anti Obesity Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Anti Obesity Drugs (Volume) by Application

3 UNITED STATES ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Anti Obesity Drugs Sales and Value (2011-2016)
  3.1.1 United States Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Anti Obesity Drugs Sales Price Trend (2011-2016)
3.2 United States Anti Obesity Drugs Sales and Market Share by Manufacturers
3.3 United States Anti Obesity Drugs Sales and Market Share by Type
3.4 United States Anti Obesity Drugs Sales and Market Share by Application

4 CHINA ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Anti Obesity Drugs Sales and Value (2011-2016)
  4.1.1 China Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Anti Obesity Drugs Sales Price Trend (2011-2016)
4.2 China Anti Obesity Drugs Sales and Market Share by Manufacturers
4.3 China Anti Obesity Drugs Sales and Market Share by Type
4.4 China Anti Obesity Drugs Sales and Market Share by Application

5 EUROPE ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Anti Obesity Drugs Sales and Value (2011-2016)
  5.1.1 Europe Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Anti Obesity Drugs Sales Price Trend (2011-2016)
5.2 Europe Anti Obesity Drugs Sales and Market Share by Manufacturers
5.3 Europe Anti Obesity Drugs Sales and Market Share by Type
5.4 Europe Anti Obesity Drugs Sales and Market Share by Application

6 JAPAN ANTI OBESITY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Anti Obesity Drugs Sales and Value (2011-2016)
  6.1.1 Japan Anti Obesity Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Anti Obesity Drugs Sales Price Trend (2011-2016)
6.2 Japan Anti Obesity Drugs Sales and Market Share by Manufacturers
6.3 Japan Anti Obesity Drugs Sales and Market Share by Type
6.4 Japan Anti Obesity Drugs Sales and Market Share by Application

7 GLOBAL ANTI OBESITY DRUGS MANUFACTURERS ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Anti Obesity Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Merck
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 118 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Roche
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 132 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 AstraZeneca
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharmaceuticals Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Eisai
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Norgine
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Arena Pharmaceuticals
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Orexigen Therapeutics
7.12 Vivus
7.13 Alizyme
7.14 Rhythm Pharmaceuticals
7.15 Shionogi
7.16 Zafgan

8 ANTI OBESITY DRUGS MAUFACTURING COST ANALYSIS

8.1 Anti Obesity Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Anti Obesity Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Anti Obesity Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTI OBESITY DRUGS MARKET FORECAST (2016-2021)

12.1 Global Anti Obesity Drugs Sales, Revenue Forecast (2016-2021)
12.2 Global Anti Obesity Drugs Sales Forecast by Regions (2016-2021)
12.3 Global Anti Obesity Drugs Sales Forecast by Type (2016-2021)
12.4 Global Anti Obesity Drugs Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti Obesity Drugs
Table Classification of Anti Obesity Drugs
Figure Global Sales Market Share of Anti Obesity Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Anti Obesity Drugs
Figure Global Sales Market Share of Anti Obesity Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure China Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Figure Global Anti Obesity Drugs Sales and Growth Rate (2011-2021)
Figure Global Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Table Global Anti Obesity Drugs Sales of Key Manufacturers (2011-2016)
Table Global Anti Obesity Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Anti Obesity Drugs Sales Share by Manufacturers
Figure 2016 Anti Obesity Drugs Sales Share by Manufacturers
Table Global Anti Obesity Drugs Revenue by Manufacturers (2011-2016)
Table Global Anti Obesity Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Anti Obesity Drugs Revenue Share by Manufacturers
Table 2016 Global Anti Obesity Drugs Revenue Share by Manufacturers
Table Global Anti Obesity Drugs Sales and Market Share by Type (2011-2016)
Table Global Anti Obesity Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Anti Obesity Drugs by Type (2011-2016)
Figure Global Anti Obesity Drugs Sales Growth Rate by Type (2011-2016)
Table Global Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
Table Global Anti Obesity Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti Obesity Drugs by Type (2011-2016)
Figure Global Anti Obesity Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Anti Obesity Drugs Sales and Market Share by Regions (2011-2016)
Table Global Anti Obesity Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Anti Obesity Drugs by Regions (2011-2016)
Figure Global Anti Obesity Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Anti Obesity Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Anti Obesity Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Anti Obesity Drugs by Regions (2011-2016)
Figure Global Anti Obesity Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Anti Obesity Drugs Sales and Market Share by Application (2011-2016)
Table Global Anti Obesity Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Anti Obesity Drugs by Application (2011-2016)
Figure Global Anti Obesity Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure United States Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure United States Anti Obesity Drugs Sales Price Trend (2011-2016)
Table United States Anti Obesity Drugs Sales by Manufacturers (2011-2016)
Table United States Anti Obesity Drugs Market Share by Manufacturers (2011-2016)
Table United States Anti Obesity Drugs Sales by Type (2011-2016)
Table United States Anti Obesity Drugs Market Share by Type (2011-2016)
Table United States Anti Obesity Drugs Sales by Application (2011-2016)
Table United States Anti Obesity Drugs Market Share by Application (2011-2016)
Figure China Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure China Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure China Anti Obesity Drugs Sales Price Trend (2011-2016)
Table China Anti Obesity Drugs Sales by Manufacturers (2011-2016)
Table China Anti Obesity Drugs Market Share by Manufacturers (2011-2016)
Table China Anti Obesity Drugs Sales by Type (2011-2016)
Table China Anti Obesity Drugs Market Share by Type (2011-2016)
Table China Anti Obesity Drugs Sales by Application (2011-2016)
Table China Anti Obesity Drugs Market Share by Application (2011-2016)
Figure Europe Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure Europe Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Anti Obesity Drugs Sales Price Trend (2011-2016)
Table Europe Anti Obesity Drugs Sales by Manufacturers (2011-2016)
Table Europe Anti Obesity Drugs Market Share by Manufacturers (2011-2016)
Table Europe Anti Obesity Drugs Sales by Type (2011-2016)
Table Europe Anti Obesity Drugs Market Share by Type (2011-2016)
Table Europe Anti Obesity Drugs Sales by Application (2011-2016)
Table Europe Anti Obesity Drugs Market Share by Application (2011-2016)
Figure Japan Anti Obesity Drugs Sales and Growth Rate (2011-2016)
Figure Japan Anti Obesity Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Anti Obesity Drugs Sales Price Trend (2011-2016)
Table Japan Anti Obesity Drugs Sales by Manufacturers (2011-2016)
Table Japan Anti Obesity Drugs Market Share by Manufacturers (2011-2016)
Table Japan Anti Obesity Drugs Sales by Type (2011-2016)
Table Japan Anti Obesity Drugs Market Share by Type (2011-2016)
Table Japan Anti Obesity Drugs Sales by Application (2011-2016)
Table Japan Anti Obesity Drugs Market Share by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Anti Obesity Drugs Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Anti Obesity Drugs Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Anti Obesity Drugs Global Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Anti Obesity Drugs Global Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Anti Obesity Drugs Global Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Anti Obesity Drugs Global Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Anti Obesity Drugs Global Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eisai Anti Obesity Drugs Global Market Share (2011-2016)
Table Norgine Basic Information List
Table Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Norgine Anti Obesity Drugs Global Market Share (2011-2016)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Arena Pharmaceuticals Anti Obesity Drugs Global Market Share (2011-2016)
Table Orexigen Therapeutics Basic Information List
Table Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Orexigen Therapeutics Anti Obesity Drugs Global Market Share (2011-2016)
Table Vivus Basic Information List
Table Vivus Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Vivus Anti Obesity Drugs Global Market Share (2011-2016)
Table Alizyme Basic Information List
Table Alizyme Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alizyme Anti Obesity Drugs Global Market Share (2011-2016)
Table Rhythm Pharmaceuticals Basic Information List
Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Rhythm Pharmaceuticals Anti Obesity Drugs Global Market Share (2011-2016)
Table Shionogi Basic Information List
Table Shionogi Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Shionogi Anti Obesity Drugs Global Market Share (2011-2016)
Table Zafgan Basic Information List
Table Zafgan Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zafgan Anti Obesity Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti Obesity Drugs
Figure Manufacturing Process Analysis of Anti Obesity Drugs
Figure Anti Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti Obesity Drugs
Table Distributors/Traders List
Figure Global Anti Obesity Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Anti Obesity Drugs Sales Forecast by Regions (2016-2021)
Table Global Anti Obesity Drugs Sales Forecast by Type (2016-2021)
Table Global Anti Obesity Drugs Sales Forecast by Application (2016-2021)